Wed, Aug 5, 2015
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Alternative Market Briefing

EDHEC- Risk seminar examines all aspects of long term rise in commodity prices

Tuesday, September 11, 2012

amb
Joelle Miffre
By Beverly Chandler, Opalesque London:

October sees a timely seminar from EDHEC- Risk Institute on commodities, in the light of increasing coverage of an expected long term rise in commodity prices, as reported in Opalesque earlier this month.

Joëlle Miffre, PhD, Professor of Finance at EDHEC Business School and a Member of EDHEC-Risk Institute will lead the Advanced Commodity Investment Seminar in New York on the 29th to the 30th of October. As a leading expert in commodity research, her work focuses on the management and pricing of commodities and equities. The intensive seminar is designed to equip participants with a comprehensive overview of commodities markets and investments, detailed knowledge of commodity futures pricing, and state-of-the art techniques for strategic and tactical asset allocation to commodities. It also sheds academic light on the financialisation of commodity markets and the role of speculators.

In an interview with Opalesque, Miffre said: "Commodities are a growing asset class so this seminar generates a lot of interest."

She agrees that over the longer term, the physics of supply and demand will ensure commodity prices will continue to rise. "In the long r......................

To view our full article Click here

Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Activist News - Celgene says patent-fighting hedge fund manager wants to short its shares[more]

    From Reuters.com: Celgene Corp, one of the world's largest biotechnology companies, has accused U.S. hedge fund manager Kyle Bass of attempting to profit from his attempts to wipe out several major drug patents through his Coalition for Affordable Drugs. The company asked the U.S. Patent and T

  2. Einhorn's Greenlight Capital hedge fund slumps 6.1 percent in July[more]

    From Reuters/Thefiscaltimes.com: Hedge fund mogul David Einhorn's Greenlight Capital slumped 6.1 percent in July and is now down 9 percent for the year after gold, one of the fund's top holdings, tumbled to five-year lows last week. Greenlight notified clients of its returns late on Friday, ac

  3. Performance - Some hedge fund small-cap energy stocks have been free falling, Dan Loeb's simple strategy destroys the market, Baupost lost 1.4% last quarter as energy bargains proved elusive[more]

    Some hedge fund small-cap energy stocks have been free falling From Marketrealist.com: According to a July 28, 2015, Bloomberg article, there was a 34% fall in small-cap energy stocks over the past three months. These shares are tracked by the Russell 2000 Energy Index. Small-cap energy

  4. Legal - Hedge funds hit Rothstein Kass with $75m malpractice suit, JPMorgan questioned on private bank’s hedge fund disclosures, Kijani fund, seized by regulators in Cayman Islands, spotlights risks in lightly regulated market[more]

    Hedge funds hit Rothstein Kass with $75m malpractice suit From Law360.com: Two investment funds have sued Rothstein Kass & Co. PC for at least $75 million, claiming the New Jersey auditing firm committed accounting malpractice by failing to properly scrutinize overblown valuations of the

  5. Assets - Hedge funds are getting smoked by the commodities slump, Global ETF assets could more than double by 2020[more]

    Hedge funds are getting smoked by the commodities slump From Businessinsider.in: The collapse in commodity prices has burnt another hedge fund. Vermillion, a commodity hedge fund backed by Carlyle Group, has seen its flagship fund's assets fall from nearly $2 billion to less $50 million,

 

banner